Lacasse Y, Israël Assayag E, Laviolette M, Cormier Y
Unité de recherche en pneumologie, Centre de recherche de l'Hôpital Laval, Institut universitaire de cardiologie et de pneumologie de l'Université Laval, Québec, Canada.
Rev Mal Respir. 2004 Sep;21(4 Pt 1):769-81. doi: 10.1016/s0761-8425(04)71418-7.
Hypersensitivity pneumonitis (HP) is a pulmonary disease with symptoms of dyspnoea and cough resulting from the inhalation of an antigen to which the patient has been previously sensitized.
Acute and subacute HP represent the most active forms of the disease which may become chronic while remaining progressive. HP may also evolve to end-stage lung disease. Clinical symptoms and signs tend to be non-specific and the diagnosis of HP often relies on the clinical context. The immune response is initiated when the alveolar macrophage phagocytoses the antigen, provoking the expansion of lymphocytes T and B that reach the pulmonary parenchyma through the systemic circulation. This reaction is amplified by the expression of a number of inflammatory mediators.
This article summarizes our current understanding of the diagnostic approach and immunological mechanisms related to HP.
过敏性肺炎(HP)是一种肺部疾病,因吸入患者先前已致敏的抗原而出现呼吸困难和咳嗽症状。
急性和亚急性HP是该疾病最活跃的形式,可能会发展为慢性且持续进展。HP也可能演变为终末期肺病。临床症状和体征往往不具有特异性,HP的诊断通常依赖于临床背景。当肺泡巨噬细胞吞噬抗原时,免疫反应启动,引发T淋巴细胞和B淋巴细胞的扩增,这些淋巴细胞通过体循环到达肺实质。多种炎症介质的表达会放大这种反应。
本文总结了我们目前对与HP相关的诊断方法和免疫机制的理解。